Is There A Relation Between Serum Uric Acid Values and Prostatic Calculi Presence?


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2019
Historique:
received: 18 09 2018
accepted: 12 11 2018
pubmed: 17 12 2018
medline: 25 7 2019
entrez: 17 12 2018
Statut: ppublish

Résumé

We planned to examine the connection between serum uric acid (UA) values and prostatic calculi (PCal) presence and to evaluate the relation between PCal and other etiological factors. Patients between 20 and 60 years of age who were referred to the clinic with any reason and had non-contrast abdominal tomography (NCACT) for PCal were included in the study. While the patients were separated into 2 groups based on their serum UA level as ≥7 mg/dL (Group 1) and < 7 mg/dL (Group 2), NCACT was also divided into 2 groups as PCal presence (PCal+) and lack (PCal-) serum UA, calcium, phosphorus, sodium, prostate-specific antigen levels and urinary analysis results of the patients were evaluated and compared. PCal were detected in 38 of 169 patients (22%). PCal presence was detected to be significantly high in Group 1 (p = 0.015). While Type A localization PCal were present both in Groups 1 and 2. Based on PCal presence, UA level was detected to be significantly high in PCal+ patients (p = 0.01). No significant difference was detected among the groups in biochemical parameters and urine-related parameters other than UA. A significant relation was found between high UA value and PCal in this study. These results may show that UA plays an active role in PCal etiology.

Identifiants

pubmed: 30554210
pii: 000495313
doi: 10.1159/000495313
doi:

Substances chimiques

Biomarkers 0
Uric Acid 268B43MJ25

Types de publication

Journal Article

Langues

eng

Pagination

199-204

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Mehmet Balasar (M)

Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Mehmet Giray Sönmez (MG)

Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey, drgiraysonmez@gmail.com.

Arif Aydın (A)

Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Yunus Emre Göger (YE)

Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Mehmet Serkan Özkent (MS)

Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Necdet Poyraz (N)

Department of Radiology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH